Genetics Company Inc., The

https://www.the-genetics.com

The Genetics Company, Inc. is a dedicated team of entrepreneurs and scientists focusing on the research, development and commercialization of innovative products for the diagnosis, therapy and therapy monitoring of patients suffering from neurodegenerative disease and cancer. Apart from a set of worldwide unique diagnostic kits and tools for the diagnosis and monitoring of patients suffering from Alzheimer's disease (AD), the Company has identified small molecule inhibitors of BACE (beta-Amyloid converting enzyme). It has also identified small molecule inhibitors of two proprietary targets within the Wnt-pathway, which is believed to play a crucial role in colon cancer. Headquartered in Zurich-Schlieren, Switzerland, the Company currently employs a staff of 24. *

	Start	1998-05-01 splitoff
	Predecessor	University of Zurich (UZH)
	Industry	pharmaceutical
	Industry 2	diagnostics (medical/biological)

	Region	Schlieren ZH
	Country	Switzerland
	Street	27 Wagistr.
	City	8952 Schlieren ZH
	Tel	+41-44-2002200
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-12-29

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]